Venture Map · Round
Ona Therapeutics — Series B · €74.2M
Announced 2026-06-04 · Barcelona · Healthtech & Bio
IRB Barcelona spin-out closed an oversubscribed €74.2M Series B co-led by Columbus and Mérieux to take its first-in-class antibody-drug conjugates against treatment-resistant breast and colorectal cancers into the clinic.
RoundSeries B
Amount€74.2M
LeadColumbus Venture Partners
Date2026-06-04
CityBarcelona
SectorHealthtech & Bio
The company
Investors 10
CColumbus Venture Partners
columbusvp.com
M
Mérieux Equity Partners
AAlta Life Sciences
altals.com
AAsabys Partners
asabys.com
B
Bpifrance
CCDTI Innvierte
cdti.es
CCOFIDES
www.cofides.es
F
Fund+
K
Korys
YYsios Capital
ysioscapital.com